The Nigeria LNG respiratory support substation at University of Abuja Teaching Hospital Gwagwalada, FCT – a preliminary report after installation
File(s) JP136A~1.PDF (464.64 KB)
Published version
Author(s)
Kudirat Olateju, Eyinade
Alabi, Ojima
Modupe Owolabi, Ruth
Onyejiaka Amadi, Hippolite
Type
Journal Article
Abstract
Respiratory distress is a common presenting clinical sign in newborn infants. It is a manifestation of several underlying conditions including congenital pneumonia, respiratory distress syndrome, sepsis, perinatal asphyxia etc; however, if not properly managed with a good respiratory support device it could lead to an unfavourable outcome.
Aim: Preliminary report on effectiveness of Politeheart CPAP device in the care of neonatal respiratory distress.
Methods: The initial phase involved training of the end-users on the principles and techniques of the new device. Thereafter, a total of 22 newborn infants with moderate to severe respiratory distress (Silverman Anderson score of 5-7) were successfully managed with the Politeheart respiratory device. Twenty of these neonates were preterm, with their gestational age ranged between 26 to 37 weeks and birthweights of 0.85 to 2.6 kg. The oxygen saturation (SPO2) response was dramatic, and most babies were discharged within 24-48 hours of intervention. None of the treated neonates received surfactants.
Conclusion: The new Politeheart CPAP is very effective for the management of neonatal respiratory distress. Furthermore, it is cost effective when compared to other respiratory support devices.
Aim: Preliminary report on effectiveness of Politeheart CPAP device in the care of neonatal respiratory distress.
Methods: The initial phase involved training of the end-users on the principles and techniques of the new device. Thereafter, a total of 22 newborn infants with moderate to severe respiratory distress (Silverman Anderson score of 5-7) were successfully managed with the Politeheart respiratory device. Twenty of these neonates were preterm, with their gestational age ranged between 26 to 37 weeks and birthweights of 0.85 to 2.6 kg. The oxygen saturation (SPO2) response was dramatic, and most babies were discharged within 24-48 hours of intervention. None of the treated neonates received surfactants.
Conclusion: The new Politeheart CPAP is very effective for the management of neonatal respiratory distress. Furthermore, it is cost effective when compared to other respiratory support devices.
Date Issued
2025-02-17
Date Acceptance
2024-12-03
Citation
Journal of Pediatrics & Neonatal Care, 2025, 15 (1), pp.52-53
ISSN
2373-4426
Publisher
MedCrave Group
Start Page
52
End Page
53
Journal / Book Title
Journal of Pediatrics & Neonatal Care
Volume
15
Issue
1
Copyright Statement
©2025 Olateju, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.
License URL
Publication Status
Published
